(Q47848957)

6 February 2018

title

Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis (English)

1 reference

6 February 2018

relapsing-remitting multiple sclerosis

main subject

multiple sclerosis

0 references

0 references

author

Frauke Zipp

1

1 reference

6 February 2018

author name string

Otzelberger K

2

1 reference

6 February 2018

Dichgans J

3

1 reference

6 February 2018

Martin R

4

1 reference

6 February 2018

Weller M

5

1 reference

6 February 2018

publication date

1 June 1998

1 reference

6 February 2018

Journal of Neuroimmunology

published in

1 reference

6 February 2018

volume

86

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

151-154

1 reference

6 February 2018

Fas ligand mediates activation-induced cell death in human T lymphocytes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Defective post-thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Cell death and birth in multiple sclerosis brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Multiple sclerosis: Fas signaling in oligodendrocyte cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Apoptosis in the nervous system in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Meta-analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900032-0

7 January 2021

10.1016/S0165-5728(98)00032-0

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018